#USA #Chicago #American Lung Association #Healthcare Providers #RSV Vaccination

American Lung Association Launches Campaign for RSV Vaccination Awareness

On October 1st, 2026, the American Lung Association (ALA) initiated a critical campaign aimed at encouraging older adults and individuals with existing health conditions to consult with their healthcare providers regarding the vaccination against Respiratory Syncytial Virus (RSV). RSV, a highly contagious virus, spreads predominantly during the colder months and can result in severe respiratory illnesses, particularly among the elderly and vulnerable populations.

Understanding RSV and Its Risks

While RSV typically causes mild symptoms in healthy individuals, its severity escalates markedly for infants and older adults. In these groups, it can lead to significant complications such as pneumonia or a worsening of pre-existing chronic health issues, which may include asthma, chronic obstructive pulmonary disease (COPD), or heart failure. For many older adults, severe RSV infections can lead to prolonged recovery times, a deterioration in the quality of life, and even a loss of autonomy in performing daily tasks.

Harold Wimmer, President and CEO of the ALA, emphasized, "Each year, RSV is associated with around 180,000 hospitalizations among adults aged 50 and above. During the previous season alone, RSV accounted for approximately 25,000 deaths across all demographics." The ALA stresses the importance of timely action as the holiday season approaches, advising older adults and those living with chronic lung conditions to take precautionary measures against RSV through vaccination and discussions with healthcare professionals.

Who Needs to Be Vaccinated?

The individuals most at risk for complications from RSV include:

• - Adults aged 75 years and older
• - Those with chronic lung or heart conditions, including asthma and COPD
• - Individuals with weakened immune systems
• - Residents of long-term care facilities and nursing homes

The U.S. Centers for Disease Control and Prevention (CDC) currently recommend a single dose of the RSV vaccine for qualifying adults, noting that it is not an annual vaccine. For adults who have already received one dose in a previous year, there is no need to get another one at this time. Importantly, vaccinations can occur year-round depending on availability, and can be combined with flu and COVID-19 shots in a single appointment.

Vaccination Gaps and Outreach Efforts

Despite the clear benefits of vaccination, current coverage rates remain disappointingly low. As of February 2026, only 43% of adults 75 and older and 33% of those between 50 and 74 with high-risk factors reported having received the RSV vaccine. There's a significant disparity within minority groups, with Hispanic and Latino adults showing particularly low vaccination rates.

The ALA's campaign encourages individuals to engage in conversations with their healthcare providers about maintaining up-to-date vaccinations against respiratory illnesses, highlighting the inclusion of the RSV vaccine for eligible adults. For further guidance on RSV prevention and vaccination, the public can visit Lung.org/rsv.

About the American Lung Association

The American Lung Association is dedicated to saving lives by promoting lung health and preventing lung diseases through comprehensive education, advocacy, and research initiatives. Focused on defeating lung cancer, championing cleaner air, enhancing the quality of life for those affected by lung illnesses, and fostering a tobacco-free future, the ALA remains a leading authority in lung health awareness. For more information or to support their mission, individuals can contact the ALA at 1-800-LUNGUSA or explore local events at Lung.org/events.

In an era where respiratory illnesses are prevalent, the ALA's proactive approach serves as a vital reminder of the importance of preventive healthcare. The successful vaccination against RSV not only protects individual health but also contributes to the overall betterment of community health, especially among the most vulnerable populations.